Šuštić, T, Bosdriesz, E, van Wageningen, S, Wessels, L F A & Bernards, R 2020, ' RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS-mutant colorectal cancer ', Translational oncology, vol. 13, no. 2, pp. 201-211 . https://doi.org/10.1016/j.tranon.2019.10.006 Translational Oncology Translational Oncology, Vol 13, Iss 2, Pp 201-211 (2020) Translational oncology, 13(2), 201-211. Neoplasia Press